Publications by authors named "John Praag"

Claim this Profile
R
Risk factors for cognitive impairment in radically treated stage III NSCLC: Secondary findings of the NVALT-11 study.
Haiyan Zeng, Lizza E L Hendriks, Willem J A Witlox, Harry J M Groen, Anne-Marie C Dingemans, John Praag

Radiother Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC.
Simon A Keek, Esma Kayan, Avishek Chatterjee, José S A Belderbos, Gerben Bootsma, John Praag

Ther Adv Med Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal delineation of the clinical target volume for thymomas in the post-resection setting: A multi-center study.
Florit Marcuse, Stephanie Peeters, Kato Herman, Femke Vaassen, Wouter van Elmpt, John Praag

Radiother Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer.
Sarah Baker, Katerina Bakunina, Marloes Duijm, Mischa S Hoogeman, Robin Cornelissen, John Praag

Radiat Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study.
Dirk De Ruysscher, Anne-Marie C Dingemans, John Praag, Jose Belderbos, Caroline Tissing-Tan

J Clin Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial.
Ben J Slotman, Corinne Faivre-Finn, Harm van Tinteren, Astrid Keijser, John Praag

Lung Cancer· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity and quality of life after high-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer.
Shafak Aluwini, Wendy M H Busser, Wendimagegn Ghidey Alemayehu, Joost L Boormans, Wim J Kirkels, John O Praag

Radiother Oncol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy for extensive stage small-cell lung cancer - Authors' reply.
Ben J Slotman, Harm van Tinteren, John O Praag, Joost L Knegjens, Sherif Y El Sharouni

Lancet· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial.
Ben J Slotman, Harm van Tinteren, John O Praag, Joost L Knegjens, Sherif Y El Sharouni

Lancet· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose-rate brachytherapy and external-beam radiotherapy for hormone-naïve low- and intermediate-risk prostate cancer: a 7-year experience.
Shafak Aluwini, Peter H van Rooij, Wim J Kirkels, Peter P Jansen, John O Praag

Int J Radiat Oncol Biol Phys· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors.
Joost J Nuyttens, Noelle C van der Voort van Zyp, John Praag, Shafak Aluwini, Rob J van Klaveren

Radiother Oncol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome.
Noëlle C van der Voort van Zyp, Jean-Briac Prévost, Mischa S Hoogeman, John Praag, Bronno van der Holt

Radiother Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDR prostate monotherapy: dosimetric effects of implant deformation due to posture change between TRUS- and CT-imaging.
Yvette Seppenwoolde, Inger-Karine Kolkman-Deurloo, Dick Sipkema, Mark de Langen, John Praag

Radiother Oncol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis